PTCT – ptc therapeutics, inc. (US:NASDAQ)
Stock Stats
News
InnovationRx: Trump Picks RFK, Jr. And Dr. Oz For Key Healthcare Roles [Forbes]
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at JPMorgan Chase & Co. from $51.00 to $62.00. They now have an "overweight" rating on the stock.
PTC Therapeutics, Inc. (NASDAQ: PTCT) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Child Thriving After Becoming World's Youngest to Receive Gene Therapy for AADC Deficiency [Yahoo! Finance]
FDA Grants Conditional Approval For PTC Therapeutics' Gene Therapy As First Ever With Direct Administration In Brain [Yahoo! Finance]
Form SC 13G/A PTC THERAPEUTICS, INC. Filed by: ARMISTICE CAPITAL, LLC
Form SC 13G/A PTC THERAPEUTICS, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Form 10-Q PTC THERAPEUTICS, INC. For: Sep 30
Form 8-K PTC THERAPEUTICS, INC. For: Nov 07
Form SC 13G/A PTC THERAPEUTICS, INC. Filed by: STATE STREET CORP
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.